Description

3-(1-Cyclohexyl-3-Pyrrolidinyl)-1,1-Diphenyl-Urea Fumarate is a high-purity, non-peptidic small molecule compound of significant interest in pharmaceutical research and development. Its primary value lies in its potent and selective antagonistic activity, making it a critical intermediate for advanced therapeutic agents. This compound is essential for researchers and manufacturers in the pharmaceutical and biotechnology sectors focused on developing novel treatments for central nervous system (CNS) disorders and other specialized medical applications.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of advanced active pharmaceutical ingredients (APIs) for neurological and psychiatric medications.
• Neuroscience Research: Used as a potent and selective reference standard in preclinical studies investigating receptor mechanisms and signal transduction pathways.
• Drug Discovery & Development: Serves as a crucial scaffold or lead compound in medicinal chemistry programs for designing new therapeutic entities.
• Reference Standard: Employed in analytical laboratories for method development, validation, and quality control testing of related pharmaceutical products.
• Biochemical Assays: Utilized in high-throughput screening (HTS) and in vitro pharmacological profiling to assess compound libraries.

Basic Information

Product Name	3-(1-Cyclohexyl-3-Pyrrolidinyl)-1,1-Diphenyl-Urea Fumarate
CAS No.	20070-52-4
Molecular Formula	C24H29N3O · C4H4O4
Molecular Weight	495.57 g/mol
Synonyms	3-(1-Cyclohexyl-3-pyrrolidinyl)-1,1-diphenylurea fumarate; 1,1-Diphenyl-3-(1-cyclohexyl-3-pyrrolidinyl)urea fumarate; 3-(1-Cyclohexylpyrrolidin-3-yl)-1,1-diphenylurea fumarate; Urea, N,N-diphenyl-N'-(1-cyclohexyl-3-pyrrolidinyl)-, (E)-2-butenedioate (1:1); Urea, 1,1-diphenyl-3-(1-cyclohexyl-3-pyrrolidinyl)-, (2E)-2-butenedioate (1:1); BCTC (fumarate salt); Contact for details on additional trade names.
EINECS	Contact for details

Quality Control

Our 3-(1-Cyclohexyl-3-Pyrrolidinyl)-1,1-Diphenyl-Urea Fumarate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical research and development. A comprehensive Certificate of Analysis (COA) detailing purity (typically ≥98% by HPLC), related substances, and other critical parameters is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Impurity	≤ 0.5%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.